Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Vaccines Market, by Region, 2020-2028(USD Billion)
1.2.2. Vaccines Market, by Type, 2020-2028(USD Billion)
1.2.3. Vaccines Market, by Technology, 2020-2028(USD Billion)
1.2.4. Vaccines Market, by Disease Indication, 2020-2028(USD Billion)
1.2.5. Vaccines Market, by Route of Administration, 2020-2028(USD Billion)
1.2.6. Vaccines Market, by Patient Type, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vaccines Market Dynamics
3.1. Vaccines Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of emerging and re-emerging infectious diseases
3.1.1.2. Increasing government support for vaccine development
3.1.2. Market Challenges
3.1.2.1. High cost of vaccine development
3.1.3. Market Opportunities
3.1.3.1. Rising inclination on therapeutic vaccines
Chapter 4. Global Vaccines Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Vaccines Market, by Type
6.1. Market Snapshot
6.2. Global Vaccines Market by Type, Performance - Potential Analysis
6.3. Global Vaccines Market Estimates & Forecasts by Type, 2019-2028 (USD Billion)
6.4. Vaccines Market, Sub Segment Analysis
6.4.1. Conjugate Vaccines
6.4.2. Inactivated and Subunit Vaccines
6.4.3. Live Attenuated Vaccines
6.4.4. Recombinant Vaccines
6.4.5. Toxoid Vaccines
Chapter 7. Global Vaccines Market, by Technology
7.1. Market Snapshot
7.2. Global Vaccines Market by Technology, Performance - Potential Analysis
7.3. Global Vaccines Market Estimates & Forecasts by Technology, 2019-2028 (USD Billion)
7.4. Vaccines Market, Sub Segment Analysis
7.4.1. Monovalent vaccines
7.4.2. Multivalent vaccines
Chapter 8. Global Vaccines Market, by Disease Indication
8.1. Market Snapshot
8.2. Global Vaccines Market by Disease Indication, Performance - Potential Analysis
8.3. Global Vaccines Market Estimates & Forecasts by Disease Indication, 2019-2028 (USD Billion)
8.4. Vaccines Market, Sub Segment Analysis
8.4.1. Pneumococcal disease
8.4.2. DTP
8.4.3. Influenza
8.4.4. HPV
8.4.5. Meningococcal disease
8.4.6. Polio
8.4.7. Rotavirus
8.4.8. Hepatitis
8.4.9. MMR
8.4.10. Varicella
8.4.11. Herpes zoster
8.4.12. Other disease indications
Chapter 9. Global Vaccines Market, by Route of Administration
9.1. Market Snapshot
9.2. Global Vaccines Market by Route of Administration, Performance - Potential Analysis
9.3. Global Vaccines Market Estimates & Forecasts by Route of Administration, 2019-2028 (USD Billion)
9.4. Vaccines Market, Sub Segment Analysis
9.4.1. Intramuscular and subcutaneous administration
9.4.2. Oral administration
9.4.3. Other routes of administration
Chapter 10. Global Vaccines Market, by Patient Type
10.1. Market Snapshot
10.2. Global Vaccines Market by Patient Type, Performance - Potential Analysis
10.3. Global Vaccines Market Estimates & Forecasts by Patient Type, 2019-2028 (USD Billion)
10.4. Vaccines Market, Sub Segment Analysis
10.4.1. Pediatric patients
10.4.2. Adult patients
Chapter 11. Global Vaccines Market, Regional Analysis
11.1. Vaccines Market, Regional Market Snapshot
11.2. North America Vaccines Market
11.2.1. U.S. Vaccines Market
11.2.1.1. Type breakdown estimates & forecasts, 2019-2028
11.2.1.2. Technology breakdown estimates & forecasts, 2019-2028
11.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2028
11.2.1.4. Route of Administration breakdown estimates & forecasts, 2019-2028
11.2.1.5. Patient Type breakdown estimates & forecasts, 2019-2028
11.2.2. Canada Vaccines Market
11.3. Europe Vaccines Market Snapshot
11.3.1. U.K. Vaccines Market
11.3.2. Germany Vaccines Market
11.3.3. France Vaccines Market
11.3.4. Spain Vaccines Market
11.3.5. Italy Vaccines Market
11.3.6. Rest of Europe Vaccines Market
11.4. Asia-Pacific Vaccines Market Snapshot
11.4.1. China Vaccines Market
11.4.2. India Vaccines Market
11.4.3. Japan Vaccines Market
11.4.4. Australia Vaccines Market
11.4.5. South Korea Vaccines Market
11.4.6. Rest of Asia Pacific Vaccines Market
11.5. Latin America Vaccines Market Snapshot
11.5.1. Brazil Vaccines Market
11.5.2. Mexico Vaccines Market
11.6. Rest of The World Vaccines Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. GlaxoSmithKline plc
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Type Summary
12.2.1.5. Recent Developments
12.2.2. Pfizer, Inc.
12.2.3. Sanofi Pasteur
12.2.4. Merck & Co., Inc.
12.2.5. CSL Limited
12.2.6. Emergent BioSolutions, Inc.
12.2.7. Johnson & Johnson
12.2.8. Serum Institute of India Pvt. Ltd.
12.2.9. Mitsubishi Tanabe Pharma Corporation
12.2.10. Panacea Biotec
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption